- 2018 Conference
- Past Conferences
- Contact Us
Nicholas “Nic” Flores is a PhD candidate in the Department of Comparative Studies at The Ohio State University and plans to graduate by Spring 2018. Nic teaches courses on literature, ethnicity, and US Latina/o experiences at OSU. Originally from a community of mostly Latina/os in the panhandle of Texas, Nic developed an interest, appreciation, and investment in the multifaceted and variegated Latina/o experiences and stories about migration, as well as individual and collective identification strategies. Nic’s commitment to embodied knowledge and transformational experience is practiced in and out of his classroom. Nic volunteers with the League of United Latin American Citizens (LULAC) Rainbow Council, one of the first in the country committed to LGBTQ Latina/os in Ohio, as well as Queer Latinx Ohio, a non-organization of people coming together around shared experiences. Nic also mentors undergraduate students with the Latino and Latin American Space for Enrichment and Research (LASER) at OSU. Nic, a student at heart, works to generate a spark of curiosity in his students the way his teachers, mentors, and friends have done for him.
Presentation: PrEParing, Protecting, and Producing the Gay Male Subject Living in the Age of Preventative Measures
Time: Breakout Session 3
This presentation examines the use of Truvada as PrEP in clinical contexts through a qualitative ethnographic investigation clinics in the central Ohio region. I investigate the clinical use and prescription of Truvada as an example of localized efforts to achieve reduced transmissions of HIV among men who have sex with men (MSM), as well as the attendant social effects this has in gay male communities. This study is interested in investigating the localized efforts and effects of Truvada as PrEP in the central Ohio region. In this presentation, I ask: What kind of user is imagined by and through the technologies, practices, and discourses regarding Truvada as PrEP and its uses? What are the implications of imagining the user thus? Who has access to Truvada? How does this drug affect people of color and their experiences seeking access to this prophylactic opportunity? What are the institutional and systemic barriers regulating Truvada?
1. The objective of this presentation is to gain insight into how Truvada as PrEP comes to matter in new ways as it moves from clinical sites and into a broader public sphere surrounding HIV/AIDS discourses and practices.
2. The object of the presentation is to share results from research conducted on Truvada as PrEP, as well develop a continuing conversation on this topic with those in the field and on the ground.
3. The object of the presentation is to share and gain knowledge from clinicians and other medical professionals in attendance.